GS-4997
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GS-4997, covering 2019-06-26 to 2019-06-26. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3 [Phase 2]